Fig. 2: Results of the RoB2 assessment for 22 randomized parallel-group trials (ordered by DiGA category, then chronologically). | npj Digital Medicine

Fig. 2: Results of the RoB2 assessment for 22 randomized parallel-group trials (ordered by DiGA category, then chronologically).

From: Healthcare effects and evidence robustness of reimbursable digital health applications in Germany: a systematic review

Fig. 2

The figure presents the RoB2 judgments for five bias domains and the overall risk of bias for each of the 22 included randomized parallel-group DiGA approval studies. Risk levels are color-coded as follows: green (low risk), yellow (some concerns), red (high risk). Figure 2 shows the studies ordered by DiGA category from the DiGA directory, as in Tables 1 and 2, then according to the chronological appearance of the study.

Back to article page